Ressources

cell-background
Publications

Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification

triangleDiscover
Publications

Targeting genome integrity dysfunctions impedes metastatic potency in non-small-cell lung cancer circulating tumor cellderived eXplants

CTC-derived eXplants (CDX) offer systems for mechanistic investigation of CTC metastatic potency and may provide rationale for biology-driven therapeutics.

triangleDiscover
Publications

STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway – Oncogene, Oct.8 2021

triangleDiscover
Publications

Paediatric Liver Cancer

A preclinical platform of mouse-transplanted human pediatric liver tumors to evaluate the efficacy of conventional and innovative anticancer therapy

triangleDiscover
news

XenTech remains fully operational after 7 weeks of COVID-19 pandemic : update from our COO

In this 7th week of containment and as end of confinement in France is announced for May 11th, I would first of all like to thank you on behalf of our teams for all the messages of support you have sent us since the beginning of the COVID-19 crisis.

triangleDiscover
news

XenTech Covid-19 management

Regarding the current circumstances, we at XenTech want you to know that we are taking the Covid-19 pandemia very seriously. We are closely monitoring the pandemic, following guidance and advice from the World Health Organization (WHO), and the French Government. 

triangleDiscover
publications

Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification

triangleDiscover
publications

Targeting genome integrity dysfunctions impedes metastatic potency in non-small-cell lung cancer circulating tumor cellderived eXplants

CTC-derived eXplants (CDX) offer systems for mechanistic investigation of CTC metastatic potency and may provide rationale for biology-driven therapeutics.

triangleDiscover
publications

STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway – Oncogene, Oct.8 2021

triangleDiscover
publications

Paediatric Liver Cancer

A preclinical platform of mouse-transplanted human pediatric liver tumors to evaluate the efficacy of conventional and innovative anticancer therapy

triangleDiscover

01Conferences
& events

06.20.22

XenTech exhibits at EACR 2022 (Seville, Jun. 20-23 2022)

We'll be exhibiting at EACR in Seville, stop by booth #50 !

triangleDiscover
04.08.22

XenTech exhibits at AACR Annual Meeting (New Orleans, Apr.8-13 2022)

We'll be exhibiting at AACR New Orleans from Apr.8th 2022, stop by our booth to chat with us (at last!)

triangleDiscover
10.05.21

XenTech live at AACR Spotlight Series

XenTech uncovers its unique dedication into PDX field to AACR attendees on Oct. 5th 2021  

triangleDiscover
10.25.21

XenTech will attend BIO-EUROPE

We’ll be delighted to present you the new products and services, reach out to us !  

triangleDiscover
cell-background

03Discover more

About us

triangleDiscover
xentech-live

Contact us

triangleDiscover